What is Apolipoprotein B (ApoB)?
ApoB (apolipoprotein B) is the structural protein carried on every atherogenic lipoprotein particle: LDL, VLDL, IDL, and Lp(a). Because each of those particles carries exactly one ApoB molecule, the serum ApoB concentration is effectively a direct particle count of total atherogenic burden. It is reported in g/L (or mg/dL) and measured from a blood sample — fasting is not strictly required, though it gives the cleanest result in people with markedly elevated triglycerides. LDL cholesterol measures the cholesterol cargo inside LDL particles, not the number of particles themselves. The two can diverge significantly: someone with many small, dense LDL particles can have a normal LDL cholesterol yet markedly elevated ApoB, because each particle carries little cholesterol but there are many of them. It is the particle count — not the cholesterol content — that determines how often particles contact the artery wall and cause damage. This is why ApoB and non-HDL cholesterol are recommended in recent European guidelines as better measures of atherogenic load than LDL cholesterol alone.
Why is Apolipoprotein B (ApoB) relevant?
ApoB is the most direct available marker for atherogenic particle burden and therefore for the risk associated with lipoprotein-driven artery wall damage. In studies comparing LDL cholesterol, non-HDL cholesterol, and ApoB as risk predictors, ApoB typically performs most strongly — especially in people with insulin resistance, elevated triglycerides, or metabolic syndrome, where LDL cholesterol most often underestimates risk. It can be a decisive addition: someone with 'normal' LDL under high triglycerides often has a shift toward smaller, denser LDL particles, so ApoB is elevated while LDL cholesterol looks normal. Conversely, someone with large, buoyant LDL can have a high LDL cholesterol with a relatively lower ApoB. That dissociation matters clinically: for setting treatment targets and evaluating response to therapy, ApoB carries the most information. European lipid guidelines use a general ApoB target of < 65–80 mg/dL (0.65–0.80 g/L) for high and very high risk; the precise bound depends on the overall risk profile.
Apolipoprotein B (ApoB) high or low — what it means
Read ApoB within the broader lipid picture: LDL cholesterol, non-HDL, triglycerides, HDL, and Lp(a). A high ApoB alongside relatively normal LDL cholesterol suggests many small, dense particles — a pattern more common in insulin resistance, high triglycerides, and a poor metabolic background. A normal ApoB with elevated LDL cholesterol points to large, buoyant particles that are on average less atherogenic, though that does not justify ignoring the LDL. For measuring the effect of lifestyle change or drug therapy (statins, PCSK9 inhibitors, inclisiran), ApoB is a useful endpoint alongside LDL cholesterol. After starting or adjusting treatment, a retest interval of 6–12 weeks is typical to see a stable new level. As with LDL, the trend across repeat measurements matters more than a single reading — one measurement tells you the direction, the repeated one confirms the durable change.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →